Europe PMC requires Javascript to function effectively.
Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please
turn on Javascript support in your web browser and reload this page.
PMC full text: | - Copyright/LicenseRequest permission to reuse
Copyright © 2019 Monfared, Jahangard, Nikkhah, Mirnajafi-Zadeh and Mowla. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
| |
Figure 4
Altered expression of miR-21 and its target genes in U87-MG cells exposed to engineered exosomes. (A) A significant elevation of miR-21 level in U87-MG cells exposed for 24 or 48 h to the exosomes obtained from pri-miR-21 expressing HEK-293T stable cells (miR-21 enriched exosomes), along with a downregulation of miR-21 in the cells treated with exosomes obtained from the miR-21-sponge expressing HEK-293T stable cell line (miR-21-sponge containing exosomes). The expression levels of miR-21 target genes PDCD4 (B) and RECK (C) revealed their expected downregulations in the cells exposed to miR-21 enriched exosomes and their upregulations in the cells exposed to the miR-21-sponge containing exosomes, at 24 and 48 h after the treatments. Exosomes obtained from mock-vectors transfected HEK-293T stable cell lines were used as controls to normalized the levels of gene expressions. *P < 0.05, **P < 0.01, ***P < 0.001, which is represented by some statistical software like Graph Pad.
Images in this article
Click on the image to see a larger version.